PHILLIP MAXWELL: Open Payments
NPI 1891120127 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,627 in 117 payments from 8 companies in 2025. Trend: 2023 $2,149 · 2024 $3,613 · 2025 $3,627
Food & beverage: $3,627
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 60 | $1,790 |
| Gilead Sciences, Inc. | 31 | $1,209 |
| Merck Sharp & Dohme LLC | 12 | $330 |
| Theratechnologies Inc. | 7 | $167 |
| Napo Pharmaceuticals Inc | 3 | $60 |
| EMD Serono, Inc. | 2 | $31 |
| TOLMAR, INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $17 |
Products named: CABENUVA, APRETUDE, DOVATO, PIFELTRO, RUKOBIA, Yeztugo, EGRIFTA, Biktarvy.
Industry payments across FL — which companies pay providers there.
